Format

Send to

Choose Destination
J Epidemiol Glob Health. 2018 Dec;8(3-4):103-105. doi: 10.2991/j.jegh.2018.04.005.

New TB Tools Need to be Affordable in the Private Sector: The Case Study of Xpert MTB/RIF.

Author information

1
Faculty of Medicine, McGill University, Montreal, Canada.
2
Foundation for Innovative New Diagnostics, Geneva, Switzerland.
3
Global Drug Facility, Stop TB Partnership, Geneva, Switzerland.
4
McGill International TB Centre, McGill University, Montreal, Canada.
5
Manipal McGill Centre for Infectious Diseases, Manipal Academy of Higher Education, Manipal, India.
PMID:
30864749
DOI:
10.2991/j.jegh.2018.04.005

Supplemental Content

Loading ...
Support Center